Nabers A. et al. [48] used immune infrared sensors to measure the secondary structure distribution of amyloid beta (Aβ) and tau in plasma and cerebrospinal fluid as structure-based biomarkers of AD. This evidence concerns the gene MAPT and Alzheimer disease.